|
Department Memorandum No. 2022-0206-A |
July 26, 2022 |
Department Memorandum No. 2022-0206-A Amendment to the DM No. 2022-0206: "Interim Operational Guidelines on the Administration of 2nd COVID-19 Vaccine Booster Doses to Senior Citizens and Frontline Healthcare Workers ages 18 years Old and Above" |
|
Department Memorandum No. 2022-0252 |
June 20, 2022 |
Interim Operational Guidelines on the Administration of Additional Doses of Pfizer-BioNTech COVID-19 Vaccine to Immunocompromised Pediatric A3 ages 12 to 17 Years Old |
|
Department Memorandum No. 2022-0259 |
June 15, 2022 |
Supplemental guidelines to the DOH-DBM JAO No. 2022-0001 for the processing of COVID-19 sickness and death compensation claims for eligible public and private health workers for calendar years 2020 and 2021 |
|
Joint Circular No. 2022-0002 |
May 12, 2022 |
Implementing Guidelines on the Grant of COVID-19 Sickness and Death Compensation to Eligible Public and Private Health Care Workers (HCWs) and Non-HCWs for FY 2022 |
|
Department Memorandum No. 2022-0204 |
May 10, 2022 |
Department Memorandum No. 2022-0204 "Guidelines on the Shifting from Pneumococcal Conjugate Vaccine 13 (PCV13) to Pneumococcal Conjugate Vaccine 10 (PCV10) in the Routine Immunization for Children" |
|
Department Memorandum No. 2022-0154 |
April 22, 2022 |
Interim operational guidelines on the administration of 2nd COVID-19 vaccine booster doses to Immunocompromised Population (ICPs) ages 18 years old and above |
|
Department Memorandum No. 2022-0141 |
March 31, 2022 |
Interim guidelines for health facilities in transition to the endemic phase of COVID-19 |
|
Department Circular No. 2022-0108 |
February 23, 2022 |
Reiteration of the PhilHealth benefit packages for inpatient management of confirmed Coronavirus Disease (COVID-19) and clarification of coverage of probable cases |
|
Department Circular No. 2021-0483-A |
February 11, 2022 |
Amendment to DC 2021-0483 entitled "Interim operational guidelines on the COVID-19 vaccination of the rest of the pediatric population ages 12-17 years old" |
|
Department Circular No. 2021-0464-B |
February 11, 2022 |
Further amendment to DC 2021-0464 entitled "Interim operational guidelines on the COVID-19 vaccination of pediatric population ages 12-17 years old with comorbidities" |
|
Joint Circular No. 2022-0001 |
February 10, 2022 |
Guidelines on the grant of one COVID-19 allowance (OCA) to Public and Private Health Care Workers (HCWs) and Non-HCW's in health facilities involved in COVID-19 response |
|
Department Memorandum 2022-0041-A |
February 04, 2022 |
Amendment to DM No. 2022-0041 dated January 24, 2022 entitled "Interim Guidelines on the management and administration of Tozinameran COVID-19 mRNA vaccine (nucleoside-modified) [Comirnaty] Pfizer COVID-19 vaccine to pediatric population ages 5-11 y/o |
